4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001179110-22-003398
Options or other derivatives
- Chief Executive Officer acquired 173,533 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Brady Stephen R Chief Executive Officer | 2022-06-21 | Grant or award · Stock Option (Right to Buy) | +173,533 | 173,533 | D | ||
Loading xslF345X03/edgar.xml…